Yatuv R, Rosenberg N, Zivelin A, Peretz H, Dardik R, Trakhtenbrot L, Seligsohn U
Institute of Thrombosis and Hemostasis, Department of Hematology, The Chaim Sheba Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Hashomer, Israel.
Blood. 2001 Aug 15;98(4):1063-9. doi: 10.1182/blood.v98.4.1063.
The most frequent mutation causing Glanzmann thrombasthenia in Iraqi-Jews (IJ-1) is an 11-bp deletion in exon 13 of the glycoprotein (GP) IIIa gene. This deletion predicts a frameshift that results in the elimination of the C406-C655 disulfide bond and a premature termination codon shortly before the transmembrane domain. To determine the contribution of each of these alterations to the thrombasthenic phenotype, Chinese hamster ovary or baby hamster kidney cells were cotransfected with normal GPIIb complementary DNA (cDNA) and the following GPIIIa cDNAs: normal, cDNA bearing IJ-1 mutation, 2011T>A mutated cDNA predicting C655S (single-letter amino acid codes) substitution, and 2019A>T mutated cDNA predicting Stop657. Elimination of the C406-C655 disulfide bond by C655S substitution did not affect GPIIb/IIIa surface expression or binding of the transfected cells to immobilized fibrinogen, whereas elimination of the transmembrane and cytoplasmic domains in IJ-1 and Stop657 mutants prevented both surface expression and binding of the transfected cells to immobilized fibrinogen. Immunohistochemical staining and immunoprecipitation demonstrated that the elimination of amino acids 657-762 in IJ-1 and Stop657 prevented intracellular GPIIb/IIIa complex formation, and differential immunofluorescence staining of GPIIIa and cellular organelles suggested that the truncated uncomplexed GPIIIa protein was retained in the endoplasmic reticulum. Because the use of GPIIIa Stop693 and normal GPIIb cDNAs yielded GPIIb/IIIa complex formation, though with lower efficiency, it is suggested that amino acids 657-692 of GPIIIa are essential for the intracellular association of GPIIb and GPIIIa. (Blood. 2001;98:1063-1069)
导致伊拉克犹太人中出现Glanzmann血小板无力症(IJ - 1)的最常见突变是糖蛋白(GP)IIIa基因第13外显子中的11个碱基对缺失。该缺失预测会导致移码,从而消除C406 - C655二硫键,并在跨膜结构域之前不久产生一个过早的终止密码子。为了确定这些改变各自对血小板无力症表型的影响,将中国仓鼠卵巢细胞或幼仓鼠肾细胞与正常GPIIb互补DNA(cDNA)以及以下GPIIIa cDNA共转染:正常的、带有IJ - 1突变的cDNA、预测C655S(单字母氨基酸代码)替代的2011T>A突变cDNA,以及预测Stop657的2019A>T突变cDNA。通过C655S替代消除C406 - C655二硫键并不影响GPIIb/IIIa的表面表达或转染细胞与固定化纤维蛋白原的结合,而IJ - 1和Stop657突变体中跨膜和胞质结构域的消除则阻止了转染细胞的表面表达以及与固定化纤维蛋白原的结合。免疫组织化学染色和免疫沉淀表明,IJ - 1和Stop657中氨基酸657 - 762的消除阻止了细胞内GPIIb/IIIa复合物的形成,并且GPIIIa与细胞器的差异免疫荧光染色表明,截短的未复合GPIIIa蛋白保留在内质网中。由于使用GPIIIa Stop693和正常GPIIb cDNA产生了GPIIb/IIIa复合物的形成,尽管效率较低,因此提示GPIIIa的氨基酸657 - 692对于GPIIb和GPIIIa的细胞内缔合至关重要。(《血液》。2001年;98:1063 - 1069)